Cardiovascular risk assessment and its association with body fat distribution pattern in young men

Introduction. Obesity is one of the key factors affecting cardiovascular risk (CVR) in young men.
Aim. To assess CVR in young men depending on the presence or absence of abdominal obesity (AO) and the type of adipose tissue (AТ) distribution.
Materials and methods. The cross-sectional clinical study included 150 men aged 20–45 years, average age 36 [32; 41] years. Participants were recruited into three groups of 50 men each, based on anthropometry and bioimpedance analysis (BIA) of body composition: Group 1 – without AO, Group 2 – with AO and predominantly subcutaneous type of AT distribution, Group 3 – with AO and predominantly visceral type of AT distribution. Anthropometric measurements, caliperometry, BIA, and ultrasound were used to assess body fat mass and AT distribution. Risk scores SCORE2, Framingham 2008, PREVENT, QRISK3, Framingham-30, and Mayo Clinic Heart Disease Risk Calculator were used to assess the CVR.
Results. In men without AO, the CVR was statistically significantly lower for all the calculated scores than in the group of men with AO and predominantly visceral fat deposition. In a correlation analysis, the number of points of CVR scores Framingham 2008, QRISK3, Framingham-30, Mayo Clinic Heart Disease Risk Calculator had positive connections with all the studied parameters of body composition (rs = 0.275–0.678; p < 0.001) and a negative relationship with the basal metabolic rate (rs = (-0.777) – (-0.285); p < 0.001).
Conclusions. Young men without AO have a lower CVR compared to men with AO and visceral fat distribution. Men with AO with predominantly subcutaneous or visceral types of AT distribution have comparable CVR, with the exception of the QRISK3 relative risk assessment and the Framingham-30 score. The CVR value positively correlates with anthropometric and ultrasound parameters reflecting the amount of visceral AT.

1. GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162–2203. https://doi.org/10.1016/S0140-6736(24)00933-4.

2. Koskinas KC, Van Craenenbroeck EM, Antoniades C, Blüher M, Gorter TM, Hanssen H et al. Obesity and cardiovascular disease: an ESC clinical consensus statement. Eur Heart J. 2024;45(38):4063–4098. https://doi.org/10.1093/eurheartj/ehae508.

3. Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984–e1010. https://doi.org/10.1161/CIR.0000000000000973.

4. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–3337. https://doi.org/10.1093/eurheartj/ehab484.

5. Boytsov SA, Pogosova NV, Ansheles AA, Badtieva VA, Balakhonova TV, Barbarash OL et al. Cardiovascular prevention 2022. Russian national guidelines. Russian Journal of Cardiology. 2023;28(5):5452. (In Russ.) https://doi.org/10.15829/1560-4071-2023-5452.

6. Preda A, Carbone F, Tirandi A, Montecucco F, Liberale L. Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management. Rev Endocr Metab Disord. 2023;24(5):901–919. https://doi.org/10.1007/s11154-023-09813-5.

7. Mohammadian Khonsari N, Khashayar P, Shahrestanaki E, Kelishadi R, Mohammadpoor Nami S, Heidari-Beni M et al. Normal Weight Obesity and

8. Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis. Front Endocrinol. 2022;13:857930. https://doi.org/10.3389/fendo.2022.857930.

9. Jacobs DR Jr, Woo JG, Sinaiko AR, Daniels SR, Ikonen J, Juonala M et al. Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events. N Engl J Med. 2022;386(20):1877–1888. https://doi.org/10.1056/NEJMoa2109191.

10. Veretyuk VV, Tsygankova OV, Ametov AS. Evaluation of a Cardiovascular Risk in Young Men. Doctor.Ru. 2023;22(4):7–17. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-4-7-17.

11. Human energy requirements: Report of a Joint FAO/WHO/UNU Expert Consultation, Rome 17–24 October 2001. Rome: United Nations University, World Health Organization, Food and Agriculture Organization of the United Nations, 2004. Available at: https://openknowledge.fao.org/server/api/core/bitstreams/65875dc7-f8c5-4a70-b0e1-f429793860ae/content.

12. Kasper AM, Langan-Evans C, Hudson JF, Brownlee TE, Harper LD, Naughton RJ et al. Come Back Skinfolds, All Is Forgiven: A Narrative Review of the Efficacy of Common Body Composition Methods in Applied Sports Practice. Nutrients. 2021;13(4):1075. https://doi.org/10.3390/nu13041075.

13. Kawamoto R, Oka Y, Tomita H, Kodama A, Ootsuka N. Association between abdominal wall fat index on ultrasonography and carotid atherosclerosis in non-obese men. J Atheroscler Thromb. 2005;12(2):85–91. https://doi.org/10.5551/jat.12.85.

14. Pimanov SI, Bondarenko VM, Makarenko EV. Choosing the Optimal Ultrasound Method for the Measurement of the Amount of Visceral Adipose Tissue. Health and Ecology Issues. 2019;(4):105–113. (In Russ.) https://doi.org/10.51523/2708-6011.2019-16-4-21.

15. Kuznetsova TYu, Chumakova GA, Druzhilov MA, Veselovskaya NG. Clinical application of quantitative echocardiographic assessment of epicardial fat tissue in obesity. Russian Journal of Cardiology. 2017;(4):81–87. (In Russ.) https://doi.org/10.15829/1560-4071-2017-4-81-87.

16. Drapkina OM, Angarsky RK, Rogozhkina EA, Maksimova OA, Ivanova AA, Zyatenkova EV, Dzhioeva ON. Ultrasound-assisted assessment of visceral and subcutaneous adipose tissue thickness. Methodological guidelines. Cardiovascular Therapy and Prevention (Russian Federation). 2023;22(3):3552. (In Russ.) https://doi.org/10.15829/1728-8800-2023-3552.

17. Ryabikov AN, Guliev ZZ, Malyutina SK, Ragino YuI. Novel ultrasonic marker of the thickness of premesenterial fat: the relationship with metabolic indicators and risk factors of cardiovascular diseases. Ateroskleroz. 2013;9(2):11–19. (In Russ.) Available at: https://ateroskleroz.elpub.ru/jour/article/view/672.

18. Anderson TS, Wilson LM, Sussman JB. Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations. JAMA Intern Med. 2024;184(8):963–970. https://doi.org/10.1001/jamainternmed.2024.1302.

19. Suzuki R, Watanabe S, Hirai Y, Akiyama K, Nishide T, Matsushima Y et al. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med. 1993;95(3):309–314. https://doi.org/10.1016/0002-9343(93)90284-v.

20. Tadokoro N, Murano S, Nishide T, Suzuki R, Watanabe S, Murayama H et al. Preperitoneal fat thickness determined by ultrasonography is correlated with coronary stenosis and lipid disorders in non-obese male subjects. Int J Obes Relat Metab Disord. 2000;24(4):502–507. https://doi.org/10.1038/sj.ijo.0801187.

21. Cigankova OV, Nikolaev KY, Fedorova EL, Bondareva ZG. Sex hormones methabolism in men through the prism of vardiovascular risk. The Journal of Atherosclerosis and Dyslipidemias. 2014;(1):17–24. (In Russ.) Available at: https://jad.noatero.ru/index.php/jad/article/view/92/91.

22. Bazzocchi A, Ponti F, Diano D, Moio A, Albisinni U, Pasquali R, Battista G. Abdominal adiposity by ultrasonography: a “pocket” database for reference standard in Italian people. Prim Care Diabetes. 2014;8(4):358–364. https://doi.org/10.1016/j.pcd.2014.02.003.

23. Kong M, Xu M, Zhou Y, Geng N, Lin N, Song W et al. Assessing Visceral Obesity and Abdominal Adipose Tissue Distribution in Healthy Populations Based on Computed Tomography: A Large Multicenter Cross-Sectional Study. Front Nutr. 2022;9:871697. https://doi.org/10.3389/fnut.2022.871697.

24. Xue R, Li Q, Geng Y, Wang H, Wang F, Zhang S. Abdominal obesity and risk of CVD: a dose-response meta-analysis of thirty-one prospective studies. Br J Nutr. 2021;126(9):1420–1430. https://doi.org/10.1017/S0007114521000064.

25. Zheng L, Sun A, Han S, Qi R, Wang R, Gong X, Xue M. Association between visceral obesity and 10-year risk of first atherosclerotic cardiovascular diseases events among American adults: National Health and Nutrition Examination Survey. Front Cardiovasc Med. 2023;10:1249401. https://doi.org/10.3389/fcvm.2023.1249401.

26. Tsygankova OV, Nikolaev KYu, Fedorova EL, Bondareva ZG, Ragino YuI, Platonov DYu, Pustovetova MG. Risk factors of cardiovascular diseases. Look at the woman. Ateroscleroz. 2014;10(1):44–55. (In Russ.) Available at: https://ateroskleroz.elpub.ru/jour/article/view/698.

27. Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation. 2010;121(15):1768–1777. https://doi.org/10.1161/CIRCULATIONAHA.109.849166.

28. Tanriover C, Copur S, Gaipov A, Ozlusen B, Akcan RE, Kuwabara M et al. Metabolically healthy obesity: Misleading phrase or healthy phenotype? Eur J Intern Med. 2023;111:5–20. https://doi.org/10.1016/j.ejim.2023.02.025.

29. Suwała S, Junik R. Body Mass Index and Waist Circumference as Predictors of Above-Average Increased Cardiovascular Risk Assessed by the SCORE2 and SCORE2-OP Calculators and the Proposition of New Optimal Cut-Off Values: Cross-Sectional Single-Center Study. J Clin Med. 2024;13(7):1931. https://doi.org/10.3390/jcm13071931.

30. Semmler G, Balcar L, Wernly S, Völkerer A, Semmler L, Hauptmann L et al. Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease. Front Endocrinol. 2023;14:1244405. https://doi.org/10.3389/fendo.2023.1244405.

31. Byambasukh O, Eisenga MF, Gansevoort RT, Bakker SJ, Corpeleijn E. Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study. Eur J Prev Cardiol. 2019;26(9):905–916. https://doi.org/10.1177/2047487319833283.

32. Bellan M, Menegatti M, Ferrari C, Carnevale Schianca GP, Pirisi M. Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice. Nutr Metab Cardiovasc Dis. 2018;28(6):610–617. https://doi.org/10.1016/j.numecd.2018.01.006.